Keyphrases
Advanced Prostate Cancer
8%
Androgen Deprivation Therapy
9%
Asia
34%
Asian Countries
16%
Benign Prostatic Hyperplasia
25%
Bladder
7%
Bladder Cancer
13%
Bladder Tumor
6%
Bone Scan
6%
Cancer Study
6%
E-cadherin
19%
E-cadherin Expression
9%
Gleason Score
6%
Hormone Therapy
12%
Immunoreactivity
6%
Indonesia
30%
Indonesian
23%
Jakarta
19%
Japan
7%
Lycopene
7%
Meta-analysis
12%
Metastasis
13%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
12%
Muscle-invasive Bladder Cancer
7%
Oncology
10%
Overall Survival
10%
Patients with Prostate Cancer
9%
Predictive Factors
7%
Progressivity
6%
Prostate
6%
Prostate Biopsy
7%
Prostate Cancer
91%
Prostate Cancer Patients
29%
Prostate Cancer Risk
8%
Prostate Cancer Screening
9%
Prostate Carcinoma
7%
Prostate Radiotherapy
10%
Prostate Volume
16%
Prostate-specific Antigen
28%
Prostate-specific Antigen Level
12%
Radical Cystectomy
9%
Radical Prostatectomy
7%
Renal Cell Carcinoma
10%
Retrospective Analysis
6%
Risk Factors
10%
Single-center Experience
6%
Transitional Cell Carcinoma
7%
Tumor
17%
Upper Tract Urothelial Carcinoma
6%
Urology
7%
Medicine and Dentistry
Androgen Deprivation Therapy
7%
Biopsy Technique
15%
Bladder
11%
Bladder Cancer
8%
Cancer Control
5%
Cancer Hormone Therapy
9%
Clear Cell Renal Cell Carcinoma
10%
COVID-19
6%
Cystectomy
6%
Diseases
10%
Histopathology
5%
Malignant Neoplasm
16%
Metastatic Carcinoma
15%
Neoplasm
14%
Oncology
10%
Overall Survival
8%
Patient Referral
6%
Predictive Factor
6%
Prostate Biopsy
7%
Prostate Cancer
100%
Prostate Carcinoma
7%
Prostate Disease
6%
Prostate Hypertrophy
22%
Prostate Specific Antigen
19%
Prostatectomy
12%
Radiation Therapy
6%
Somatomedin
6%
Transitional Cell Carcinoma
19%
Transrectal Ultrasonography
9%
Urologist
5%
Urology
7%